Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Stoeltzing

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Annals of Surgical Oncology|August 9, 2002
Role of angiogenesis in the development and growth of liver metastasisAkihiko Takeda, Oliver Stoeltzing, Syed A Ahmad, et al.
BMC Cancer|July 25, 2008
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivoChristian Moser, Sven A Lang, Akira Mori, et al.
Microscopy Research and Technique|January 23, 2003
Biology of angiogenesis in tumors of the gastrointestinal tractNiels Reinmuth, Alexander A Parikh, Syed A Ahmad, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2008
Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesisChristian Moser, Philipp Schachtschneider, Sven A Lang, et al.
Molecular Cancer Research : MCR|August 13, 2009
Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alphaAkira Mori, Christian Moser, Sven A Lang, et al.
Biochimica Et Biophysica Acta|February 2, 2010
Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cellsSven A Lang, Christina Hackl, Christian Moser, et al.
Cancer Research|June 5, 2003
Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cellsMatthew H Herynk, Oliver Stoeltzing, Niels Reinmuth, et al.
Molecular Cancer Therapeutics|September 16, 2004
ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancerMarya F McCarty, Jane Wey, Oliver Stoeltzing, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in miceSven A Lang, Christian Moser, Stefan Fichnter-Feigl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancerNiels Reinmuth, Wenbiao Liu, Fan Fan, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Annals of Surgical Oncology|August 9, 2002
Role of angiogenesis in the development and growth of liver metastasisAkihiko Takeda, Oliver Stoeltzing, Syed A Ahmad, et al.
BMC Cancer|July 25, 2008
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivoChristian Moser, Sven A Lang, Akira Mori, et al.
Microscopy Research and Technique|January 23, 2003
Biology of angiogenesis in tumors of the gastrointestinal tractNiels Reinmuth, Alexander A Parikh, Syed A Ahmad, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2008
Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesisChristian Moser, Philipp Schachtschneider, Sven A Lang, et al.
Molecular Cancer Research : MCR|August 13, 2009
Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alphaAkira Mori, Christian Moser, Sven A Lang, et al.
Biochimica Et Biophysica Acta|February 2, 2010
Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cellsSven A Lang, Christina Hackl, Christian Moser, et al.
Cancer Research|June 5, 2003
Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cellsMatthew H Herynk, Oliver Stoeltzing, Niels Reinmuth, et al.
Molecular Cancer Therapeutics|September 16, 2004
ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancerMarya F McCarty, Jane Wey, Oliver Stoeltzing, et al.
Hepatology (Baltimore, Md.)|December 17, 2008
Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in miceSven A Lang, Christian Moser, Stefan Fichnter-Feigl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancerNiels Reinmuth, Wenbiao Liu, Fan Fan, et al.
Pageof 6